{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T17:42:18Z","timestamp":1793900538363,"version":"4.8.0"},"reference-count":166,"publisher":"Portland Press Ltd.","issue":"1","license":[{"start":{"date-parts":[[2023,1,24]],"date-time":"2023-01-24T00:00:00Z","timestamp":1674518400000},"content-version":"vor","delay-in-days":23,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,1,31]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer-related death worldwide. In the recent years nonalcoholic fatty liver disease (NAFLD) is becoming a growing cause of HCCs and the incidence of NAFLD-related HCCs is expected to further dramatically increase by the next decade. Chronic inflammation is regarded as the driving force of NAFLD progression and a key factor in hepatic carcinogenesis. Hepatic inflammation in NAFLD results from the persistent stimulation of innate immunity in response to hepatocellular injury and gut dysbiosis as well as by the activation of adaptive immunity. However, the relative roles of innate and adaptive immunity in the processes leading to HCC are still incompletely characterized. This is due to the complex interplay between different liver cell populations, which is also strongly influenced by gut-derived bacterial products, metabolic\/nutritional signals. Furthermore, carcinogenic mechanisms in NAFLD\/NASH appear to involve the activation of signals mediated by hypoxia inducible factors. This review discusses recent data regarding the contribution of different inflammatory cells to NAFLD-related HCC and their possible impact on patient response to current treatments.<\/jats:p>","DOI":"10.1042\/bsr20221271","type":"journal-article","created":{"date-parts":[[2023,1,24]],"date-time":"2023-01-24T07:30:33Z","timestamp":1674545433000},"update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Inflammatory processes involved in NASH-related hepatocellular carcinoma"],"prefix":"10.1042","volume":"43","author":[{"given":"Stefania","family":"Cannito","sequence":"first","affiliation":[{"name":"1Department of Clinical and Biological Sciences, Unit of Experimental Medicine and Clinical Pathology, University of Turin, Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umberto","family":"Dianzani","sequence":"additional","affiliation":[{"name":"2Department of Health Sciences and Interdisciplinary Research Centre for Autoimmune Diseases, University of East Piedmont, Novara, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Parola","sequence":"additional","affiliation":[{"name":"1Department of Clinical and Biological Sciences, Unit of Experimental Medicine and Clinical Pathology, University of Turin, Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4738-7049","authenticated-orcid":false,"given":"Emanuele","family":"Albano","sequence":"additional","affiliation":[{"name":"2Department of Health Sciences and Interdisciplinary Research Centre for Autoimmune Diseases, University of East Piedmont, Novara, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Sutti","sequence":"additional","affiliation":[{"name":"2Department of Health Sciences and Interdisciplinary Research Centre for Autoimmune Diseases, University of East Piedmont, Novara, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"288","published-online":{"date-parts":[[2023,1,24]]},"reference":[{"key":"2023012407301962400_B1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"2023012407301962400_B2","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.jhep.2018.05.036","article-title":"Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030","volume":"69","author":"Estes","year":"2018","journal-title":"J. Hepatol."},{"key":"2023012407301962400_B3","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"George1 J. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J. Hepatol."},{"key":"2023012407301962400_B4","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet"},{"key":"2023012407301962400_B5","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1056\/NEJMra1713263","article-title":"Hepatocellular Carcinoma","volume":"380","author":"Villanueva","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"2023012407301962400_B6","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s41575-020-00381-6","article-title":"Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention","volume":"18","author":"Huang","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"2023012407301962400_B7","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1002\/hep.32542","article-title":"NAFLD-related hepatocellular carcinoma: The growing challenge","volume":"77","author":"Shah","year":"2023","journal-title":"Hepatology"},{"key":"2023012407301962400_B8","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.3748\/wjg.v25.i14.1653","article-title":"Update on hepatocellular carcinoma: Pathologists\u2019 review","volume":"25","author":"El Jabbour","year":"2019","journal-title":"World J. Gastroenterol."},{"key":"2023012407301962400_B9","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.dld.2021.06.023","article-title":"Distinctive features of hepatocellular carcinoma in non-alcoholic fatty liver disease","volume":"54","author":"Valenti","year":"2022","journal-title":"Dig. Liver Dis."},{"key":"2023012407301962400_B10","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.jhep.2021.04.049","article-title":"Molecular characterisation of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis","volume":"75","author":"Pinyol","year":"2021","journal-title":"J. Hepatol."},{"key":"2023012407301962400_B11","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.cmet.2018.10.012","article-title":"Preclinical models for studying NASH-driven HCC: how useful are they?","volume":"29","author":"Febbraio","year":"2019","journal-title":"Cell Metab."},{"key":"2023012407301962400_B12","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.ccell.2014.09.003","article-title":"Metabolic activation of intrahepatic CD8+ T cells and NKT cells causes nonalcoholic steatohepatitis and liver cancer via cross-talk with hepatocytes","volume":"26","author":"Wolf","year":"2014","journal-title":"Cancer Cell."},{"key":"2023012407301962400_B13","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.ccell.2016.05.020","article-title":"Metabolic inflammation-associated IL-17A causes non-alcoholic steatohepatitis and hepatocellular carcinoma","volume":"30","author":"Gomes","year":"2016","journal-title":"Cancer Cell."},{"key":"2023012407301962400_B14","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.jcmgh.2021.10.002","article-title":"Hepatocyte-specific deletion of HIF2\u03b1 prevents NASH-related liver carcinogenesis by decreasing cancer cell proliferation","volume":"3","author":"Foglia","year":"2022","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"2023012407301962400_B15","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1055\/s-0038-1676806","article-title":"Inflammation and liver cancer: molecular mechanisms and therapeutic targets","volume":"39","author":"Yang","year":"2019","journal-title":"Semin. Liver Dis."},{"key":"2023012407301962400_B16","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/s41575-019-0145-7","article-title":"From NASH to HCC: current concepts and future challenges","volume":"16","author":"Anstee","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"2023012407301962400_B17","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nrgastro.2015.200","article-title":"Immunology in the liver\u2013from homeostasis to disease","volume":"13","author":"Heymann","year":"2016","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"2023012407301962400_B18","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3390\/biomedicines10010083","article-title":"Intestinal barrier and permeability in health, obesity and NAFLD","volume":"10","author":"Portincasa","year":"2021","journal-title":"Biomedicines"},{"key":"2023012407301962400_B19","doi-asserted-by":"publisher","first-page":"159209","DOI":"10.1016\/j.bbalip.2022.159209","article-title":"Integrating the contributions of mitochondrial oxidative metabolism to lipotoxicity and inflammation in NAFLD pathogenesis","volume":"1867","author":"Hughey","year":"2022","journal-title":"Biochim. Biophys. Acta Mol. Cell. Biol. Lipids"},{"key":"2023012407301962400_B20","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3390\/biom12010056","article-title":"Understanding the role of the gut microbiome and microbial metabolites in non-alcoholic fatty liver disease: current evidence and perspectives","volume":"12","author":"Vallianou","year":"2021","journal-title":"Biomolecules"},{"key":"2023012407301962400_B21","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/jgh.15713","article-title":"Diet and gut microbiome in fatty liver and its associated liver cancer","volume":"37","author":"Pan","year":"2022","journal-title":"J. Gastroenterol. Hepatol."},{"key":"2023012407301962400_B22","doi-asserted-by":"publisher","first-page":"867940","DOI":"10.3389\/fendo.2022.867940","article-title":"Hepatic stellate cell-immune interactions in NASH","volume":"13","author":"Carter","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"2023012407301962400_B23","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.jceh.2021.08.029","article-title":"Hepatic regeneration in cirrhosis","volume":"12","author":"Jindal","year":"2022","journal-title":"J. Clin. Exp. Hepatol."},{"key":"2023012407301962400_B24","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1007\/s00535-012-0739-0","article-title":"Increased hepatic oxidative DNA damage in patients with nonalcoholic steatohepatitis who develop hepatocellular carcinoma","volume":"48","author":"Tanaka","year":"2013","journal-title":"J. Gastroenterol."},{"key":"2023012407301962400_B25","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.jhepr.2019.10.001","article-title":"Platelets in chronic liver disease, from bench to bedside","volume":"1","author":"Ramadori","year":"2019","journal-title":"JHEP Rep."},{"key":"2023012407301962400_B26","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1038\/s41591-019-0379-5","article-title":"Platelet GPIb\u03b1 is a mediator and potential interventional target for NASH and subsequent liver cancer","volume":"25","author":"Malehmir","year":"2019","journal-title":"Nat. Med."},{"key":"2023012407301962400_B27","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1111\/j.1742-1241.2005.00500.x","article-title":"The mean platelet volume in patients with obesity","volume":"59","author":"Coban","year":"2005","journal-title":"Int. J. Clin. Pract."},{"key":"2023012407301962400_B28","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1002\/hep.24721","article-title":"Mean platelet volume as a marker of increased cardiovascular risk in patients with nonalcoholic steatohepatitis","volume":"55","author":"Alkhouri","year":"2012","journal-title":"Hepatology"},{"key":"2023012407301962400_B29","doi-asserted-by":"publisher","first-page":"5489","DOI":"10.4049\/jimmunol.1001623","article-title":"Lipopolysaccharide signaling without a nucleus: kinase cascades stimulate platelet shedding of proinflammatory IL-1\u03b2-rich microparticles","volume":"186","author":"Brown","year":"2011","journal-title":"J. Immunol."},{"key":"2023012407301962400_B30","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1111\/jth.13147","article-title":"Platelet secretory behaviour: as diverse as the granules \u2026 or not?","volume":"13","author":"Heijnen","year":"2015","journal-title":"J. Thromb. Haemost."},{"key":"2023012407301962400_B31","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.3389\/fphar.2019.01256","article-title":"Platelet-derived extracellular vesicles as target of antiplatelet agents. what is the evidence?","volume":"10","author":"Taus","year":"2019","journal-title":"Front. Pharmacol."},{"key":"2023012407301962400_B32","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.semcancer.2010.04.005","article-title":"Selectins promote tumor metastasis","volume":"20","author":"L\u00e4ubli","year":"2010","journal-title":"Semin. Cancer Biol."},{"key":"2023012407301962400_B33","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/s41575-019-0210-2","article-title":"Adaptive immunity: an emerging player in the progression of NAFLD","volume":"17","author":"Sutti","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"2023012407301962400_B34","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1053\/j.gastro.2014.07.056","article-title":"Pathological features of fatty liver disease","volume":"147","author":"Yeh","year":"2014","journal-title":"Gastroenterology"},{"key":"2023012407301962400_B35","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.freeradbiomed.2018.06.015","article-title":"B2-Lymphocyte responses to oxidative stress-derived antigens contribute to the evolution of nonalcoholic fatty liver disease (NAFLD)","volume":"124","author":"Bruzz\u00ec","year":"2018","journal-title":"Free Radic. Biol. Med."},{"key":"2023012407301962400_B36","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1002\/hep.32336","article-title":"T cells: Friends and foes in NASH pathogenesis and hepatocarcinogenesis","volume":"75","author":"Ramadori","year":"2022","journal-title":"Hepatology"},{"key":"2023012407301962400_B37","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1002\/hep.31755","article-title":"Microbiota-driven activation of intrahepatic B cells aggravates NASH through innate and adaptive signaling","volume":"74","author":"Barrow","year":"2021","journal-title":"Hepatology"},{"key":"2023012407301962400_B38","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/s41577-021-00639-3","article-title":"Immune cell-mediated features of non-alcoholic steatohepatitis","volume":"22","author":"Huby","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"2023012407301962400_B39","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1186\/s40425-019-0749-z","article-title":"Immunotherapy in hepatocellular carcinoma: the complex interface between inflammation, fibrosis, and the immune response","volume":"7","author":"Keenan","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"2023012407301962400_B40","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/j.jhep.2021.07.032","article-title":"Regulatory T-cell and neutrophil extracellular trap interaction contributes to carcinogenesis in non-alcoholic steatohepatitis","volume":"75","author":"Wang","year":"2021","journal-title":"J. Hepatol."},{"key":"2023012407301962400_B41","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/s41586-021-03362-0","article-title":"NASH limits anti-tumour surveillance in immunotherapy-treated HCC","volume":"592","author":"Pfister","year":"2021","journal-title":"Nature"},{"key":"2023012407301962400_B42","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41575-018-0009-6","article-title":"Triggering and resolution of inflammation in NASH","volume":"15","author":"Schuster","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"2023012407301962400_B43","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1055\/s-0037-1604480","article-title":"Macrophages in nonalcoholic fatty liver disease: a role model of pathogenic immunometabolism","volume":"37","author":"Krenkel","year":"2017","journal-title":"Semin. Liver Dis."},{"key":"2023012407301962400_B44","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1194\/jlr.M034876","article-title":"Hepatic cholesterol crystals and crown-like structures distinguish NASH from simple steatosis","volume":"54","author":"Ioannou","year":"2013","journal-title":"J. Lipid Res."},{"key":"2023012407301962400_B45","doi-asserted-by":"publisher","first-page":"644.e5","DOI":"10.1016\/j.molcel.2019.07.028","article-title":"Landscape of intercellular crosstalk in healthy and NASH liver revealed by single-cell secretome gene analysis","volume":"75","author":"Xiong","year":"2019","journal-title":"Mol. Cell."},{"key":"2023012407301962400_B46","doi-asserted-by":"publisher","first-page":"108626","DOI":"10.1016\/j.celrep.2020.108626","article-title":"Dynamic shifts in the composition of resident and recruited macrophages influence tissue remodeling in NASH","volume":"34","author":"Daemen","year":"2021","journal-title":"Cell Rep."},{"key":"2023012407301962400_B47","doi-asserted-by":"publisher","first-page":"1057.e7","DOI":"10.1016\/j.immuni.2020.04.001","article-title":"Niche-specific reprogramming of epigenetic landscapes drives myeloid cell diversity in nonalcoholic steatohepatitis","volume":"52","author":"Seidman","year":"2020","journal-title":"Immunity"},{"key":"2023012407301962400_B48","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/s41586-019-1631-3","article-title":"Resolving the fibrotic niche of human liver cirrhosis at single-cell level","volume":"575","author":"Ramachandran","year":"2019","journal-title":"Nature"},{"key":"2023012407301962400_B49","doi-asserted-by":"publisher","first-page":"e82163","DOI":"10.1371\/journal.pone.0082163","article-title":"Hepatic crown-like structure: a unique histological feature in non-alcoholic steatohepatitis in mice and humans","volume":"8","author":"Itoh","year":"2013","journal-title":"PLoS ONE"},{"key":"2023012407301962400_B50","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1194\/jlr.M072454","article-title":"Cholesterol crystallization within hepatocyte lipid droplets and its role in murine NASH","volume":"58","author":"Ioannou","year":"2017","journal-title":"J. Lipid Res."},{"key":"2023012407301962400_B51","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.3389\/fimmu.2020.01169","article-title":"Crosstalk between liver macrophages and surrounding cells in nonalcoholic steatohepatitis","volume":"11","author":"Li","year":"2020","journal-title":"Front. Immunol."},{"key":"2023012407301962400_B52","doi-asserted-by":"publisher","first-page":"16727","DOI":"10.1038\/s41598-021-96076-2","article-title":"Key features of the environment promoting liver cancer in the absence of cirrhosis","volume":"11","author":"Zaki","year":"2021","journal-title":"Sci. Rep."},{"key":"2023012407301962400_B53","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.jhep.2016.07.011","article-title":"Determinants of hepatic effector CD8+ T cell dynamics","volume":"66","author":"Benechet","year":"2017","journal-title":"J. Hepatol."},{"key":"2023012407301962400_B54","doi-asserted-by":"publisher","first-page":"848367","DOI":"10.3389\/fimmu.2022.848367","article-title":"Integrated analysis highlights the immunosuppressive role of TREM2+ macrophages in hepatocellular carcinoma","volume":"13","author":"Zhou","year":"2022","journal-title":"Front. Immunol."},{"key":"2023012407301962400_B55","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1136\/gutjnl-2019-319227","article-title":"TREM-2 defends the liver against hepatocellular carcinoma through multifactorial protective mechanisms","volume":"70","author":"Esparza-Baquer","year":"2021","journal-title":"Gut"},{"key":"2023012407301962400_B56","doi-asserted-by":"publisher","first-page":"616044","DOI":"10.3389\/fimmu.2020.616044","article-title":"Trem-2 promotes emergence of restorative macrophages and endothelial cells during recovery from hepatic tissue damage","volume":"11","author":"Coelho","year":"2021","journal-title":"Front. Immunol."},{"key":"2023012407301962400_B57","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32620","article-title":"Circulating TREM2 as a noninvasive diagnostic biomarker for NASH in patients with elevated liver stiffness","author":"Indira Chandran","year":"2022","journal-title":"Hepatology"},{"key":"2023012407301962400_B58","doi-asserted-by":"publisher","first-page":"751802","DOI":"10.3389\/fendo.2021.751802","article-title":"Role of neutrophils in the pathogenesis of nonalcoholic steatohepatitis","volume":"12","author":"Hwang","year":"2021","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"2023012407301962400_B59","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1126\/science.1092385","article-title":"Neutrophil extracellular traps kill bacteria","volume":"303","author":"Brinkmann","year":"2004","journal-title":"Science"},{"key":"2023012407301962400_B60","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1002\/hep.29914","article-title":"Neutrophil extracellular traps promote inflammation and development of hepatocellular carcinoma in nonalcoholic steatohepatitis","volume":"68","author":"van der Windt","year":"2018","journal-title":"Hepatology"},{"key":"2023012407301962400_B61","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nm1565","article-title":"Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood","volume":"13","author":"Clark","year":"2007","journal-title":"Nat. Med."},{"key":"2023012407301962400_B62","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s12020-017-1323-4","article-title":"Neutrophil depletion improves diet-induced non-alcoholic fatty liver disease in mice","volume":"57","author":"Ou","year":"2017","journal-title":"Endocrine"},{"key":"2023012407301962400_B63","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/s41575-021-00568-5","article-title":"Neutrophils as potential therapeutic targets in hepatocellular carcinoma","volume":"19","author":"Geh","year":"2022","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"2023012407301962400_B64","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1182\/blood-2018-11-844548","article-title":"Neutrophil plasticity in the tumor microenvironment","volume":"133","author":"Giese","year":"2019","journal-title":"Blood"},{"key":"2023012407301962400_B65","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.ccr.2009.06.017","article-title":"Polarization of tumor-associated neutrophil phenotype by TGF-beta: \u201cN1\u201d versus \u201cN2\u201d TAN","volume":"16","author":"Fridlender","year":"2009","journal-title":"Cancer Cell."},{"key":"2023012407301962400_B66","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1136\/gutjnl-2021-326259","article-title":"CXCR2 inhibition enables NASH-HCC immunotherapy","volume":"71","author":"Leslie","year":"2022","journal-title":"Gut"},{"key":"2023012407301962400_B67","doi-asserted-by":"publisher","first-page":"946","DOI":"10.3389\/fimmu.2019.00946","article-title":"Hepatic natural killer cells: organ-specific sentinels of liver immune homeostasis and physiopathology","volume":"10","author":"Mikulak","year":"2019","journal-title":"Front. Immunol."},{"key":"2023012407301962400_B68","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1038\/nri3065","article-title":"Organ-specific features of natural killer cells","volume":"11","author":"Shi","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"2023012407301962400_B69","doi-asserted-by":"publisher","first-page":"640869","DOI":"10.3389\/fimmu.2021.640869","article-title":"Revisiting the role of natural killer cells in non-alcoholic fatty liver disease","volume":"12","author":"Mart\u00ednez-Chantar","year":"2021","journal-title":"Front. Immunol."},{"key":"2023012407301962400_B70","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.jcmgh.2021.08.019","article-title":"Activated natural killer cell promotes nonalcoholic steatohepatitis through mediating JAK\/STAT pathway","volume":"13","author":"Wang","year":"2022","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"2023012407301962400_B71","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.3389\/fimmu.2019.01255","article-title":"Retained NK cell phenotype and functionality in non-alcoholic fatty liver disease","volume":"10","author":"Stiglund","year":"2019","journal-title":"Front. Immunol."},{"key":"2023012407301962400_B72","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.4049\/jimmunol.1302765","article-title":"The transcription factor E4BP4 is not required for extramedullary pathways of NK cell development","volume":"192","author":"Crotta","year":"2014","journal-title":"J. Immunol."},{"key":"2023012407301962400_B73","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1002\/hep.28389","article-title":"NKp46(+) natural killer cells attenuate metabolism-induced hepatic fibrosis by regulating macrophage activation in mice","volume":"63","author":"Tosello-Trampont","year":"2016","journal-title":"Hepatology"},{"key":"2023012407301962400_B74","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1158\/0008-5472.CAN-19-2332","article-title":"Tim-3 hampers tumor surveillance of liver-resident and conventional NK cells by disrupting PI3K signaling","volume":"80","author":"Tan","year":"2020","journal-title":"Cancer Res."},{"key":"2023012407301962400_B75","doi-asserted-by":"publisher","first-page":"1035950","DOI":"10.3389\/fimmu.2022.1035950","article-title":"New insights into iNKT cells and their roles in liver diseases","volume":"13","author":"Gu","year":"2022","journal-title":"Front. Immunol."},{"key":"2023012407301962400_B76","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1136\/gutjnl-2011-301857","article-title":"NKT-associated hedgehog and osteopontin drive fibrogenesis in non-alcoholic fatty liver disease","volume":"61","author":"Syn","year":"2012","journal-title":"Gut"},{"key":"2023012407301962400_B77","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1042\/CS20120289","article-title":"NF-\u03baB1 deficiency stimulates the progression of non-alcoholic steatohepatitis (NASH) in mice by promoting NKT-cell-mediated responses","volume":"124","author":"Locatelli","year":"2013","journal-title":"Clin. Sci. (Lond.)"},{"key":"2023012407301962400_B78","doi-asserted-by":"publisher","first-page":"3017","DOI":"10.4049\/jimmunol.1800614","article-title":"Differential activation of hepatic invariant NKT cell subsets plays a key role in progression of nonalcoholic steatohepatitis","volume":"201","author":"Maricic","year":"2018","journal-title":"J. Immunol."},{"key":"2023012407301962400_B79","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s12072-012-9345-8","article-title":"B cell-activating factor is associated with the histological severity of nonalcoholic fatty liver disease","volume":"7","author":"Miyake","year":"2013","journal-title":"Hepatol. Int."},{"key":"2023012407301962400_B80","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1002\/hep.26749","article-title":"Adaptive immune responses triggered by oxidative stress contribute to hepatic inflammation in NASH","volume":"59","author":"Sutti","year":"2014","journal-title":"Hepatology"},{"key":"2023012407301962400_B81","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1111\/1751-2980.12362","article-title":"Role of intrahepatic B cells in non-alcoholic fatty liver disease by secreting pro-inflammatory cytokines and regulating intrahepatic T cells","volume":"17","author":"Zhang","year":"2016","journal-title":"J Dig Dis."},{"key":"2023012407301962400_B82","doi-asserted-by":"publisher","first-page":"3072","DOI":"10.1172\/JCI24798","article-title":"Attenuated liver fibrosis in the absence of B cells","volume":"115","author":"Novobrantseva","year":"2005","journal-title":"J. Clin. Invest."},{"key":"2023012407301962400_B83","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1002\/hep.27761","article-title":"Liver fibrosis occurs through dysregulation of MyD88-dependent innate B-cell activity","volume":"61","author":"Thapa","year":"2015","journal-title":"Hepatology"},{"key":"2023012407301962400_B84","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1002\/hep.29636","article-title":"B lymphocytes limit senescence-driven fibrosis resolution and favor hepatocarcinogenesis in mouse liver injury","volume":"67","author":"Faggioli","year":"2018","journal-title":"Hepatology"},{"key":"2023012407301962400_B85","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/j.jhep.2014.01.010","article-title":"Serum immunoglobulin levels predict fibrosis in patients with non-alcoholic fatty liver disease","volume":"60","author":"McPherson","year":"2014","journal-title":"J. Hepatol."},{"key":"2023012407301962400_B86","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/nature24302","article-title":"Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity","volume":"551","author":"Shalapour","year":"2017","journal-title":"Nature"},{"key":"2023012407301962400_B87","doi-asserted-by":"publisher","first-page":"596318","DOI":"10.3389\/fonc.2020.596318","article-title":"Single-Cell RNA-Seq analysis reveals microenvironmental infiltration of plasma cells and hepatocytic prognostic markers in hcc with cirrhosis","volume":"10","author":"Zhang","year":"2020","journal-title":"Front. Oncol."},{"key":"2023012407301962400_B88","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1007\/s10875-011-9571-1","article-title":"Altered phenotype and functionality of circulating immune cells characterize adult patients with nonalcoholic steatohepatitis","volume":"31","author":"Inzaugarat","year":"2011","journal-title":"J. Clin. Immunol."},{"key":"2023012407301962400_B89","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1007\/s10875-011-9635-2","article-title":"The role of innate cells is coupled to a Th1-polarized immune response in pediatric nonalcoholic steatohepatitis","volume":"32","author":"Ferreyra Solari","year":"2012","journal-title":"J. Clin. Immunol."},{"key":"2023012407301962400_B90","doi-asserted-by":"publisher","first-page":"G891","DOI":"10.1152\/ajpgi.00193.2013","article-title":"IFN-\u03b3 deficiency attenuates hepatic inflammation and fibrosis in a steatohepatitis model induced by a methionine- and choline-deficient high-fat diet","volume":"305","author":"Luo","year":"2013","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"2023012407301962400_B91","doi-asserted-by":"publisher","first-page":"580968","DOI":"10.3389\/fimmu.2020.580968","article-title":"CD4+ T cells mediate the development of liver fibrosis in high fat diet-induced NAFLD in humanized mice","volume":"11","author":"Her","year":"2020","journal-title":"Front. Immunol."},{"key":"2023012407301962400_B92","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1042\/CS20150405","article-title":"The balance between IL-17 and IL-22 produced by liver-infiltrating T-helper cells critically controls NASH development in mice","volume":"130","author":"Rolla","year":"2016","journal-title":"Clin. Sci. (Lond.)"},{"key":"2023012407301962400_B93","doi-asserted-by":"publisher","first-page":"239623","DOI":"10.1155\/2015\/239623","article-title":"CD4+ROR \u03b3 t++ and tregs in a mouse model of diet-induced nonalcoholic steatohepatitis","volume":"2015","author":"Vonghia","year":"2015","journal-title":"Mediators Inflamm."},{"key":"2023012407301962400_B94","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1111\/j.1365-2249.2011.04471.x","article-title":"Interleukin-17 exacerbates hepatic steatosis and inflammation in non-alcoholic fatty liver disease","volume":"166","author":"Tang","year":"2011","journal-title":"Clin. Exp. Immunol."},{"key":"2023012407301962400_B95","doi-asserted-by":"publisher","first-page":"e0149783","DOI":"10.1371\/journal.pone.0149783","article-title":"Regulation of inflammation by IL-17A and IL-17F modulates non-alcoholic fatty liver disease pathogenesis","volume":"11","author":"Giles","year":"2016","journal-title":"PLoS ONE"},{"key":"2023012407301962400_B96","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12865-017-0215-y","article-title":"The imbalance of Th17\/Treg cells is involved in the progression of nonalcoholic fatty liver disease in mice","volume":"18","author":"He","year":"2017","journal-title":"BMC Immunol."},{"key":"2023012407301962400_B97","doi-asserted-by":"publisher","first-page":"1187.e9","DOI":"10.1016\/j.cmet.2021.04.018","article-title":"PKM2-dependent metabolic skewing of hepatic Th17 cells regulates pathogenesis of non-alcoholic fatty liver disease","volume":"33","author":"Moreno-Fernandez","year":"2021","journal-title":"Cell Metab."},{"key":"2023012407301962400_B98","doi-asserted-by":"publisher","first-page":"3786.e4","DOI":"10.1016\/j.celrep.2018.12.006","article-title":"OX40 regulates both innate and adaptive immunity and promotes nonalcoholic steatohepatitis","volume":"25","author":"Sun","year":"2018","journal-title":"Cell Rep."},{"key":"2023012407301962400_B99","doi-asserted-by":"publisher","first-page":"3925","DOI":"10.4049\/jimmunol.1400861","article-title":"IL-17A enhances the expression of profibrotic genes through upregulation of the TGF-\u03b2 receptor on hepatic stellate cells in a JNK-dependent manner","volume":"193","author":"Fabre","year":"2014","journal-title":"J. Immunol."},{"key":"2023012407301962400_B100","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/s41586-021-03233-8","article-title":"Auto-aggressive CXCR6+ CD8 T cells cause liver immune pathology in NASH","volume":"592","author":"Dudek","year":"2021","journal-title":"Nature"},{"key":"2023012407301962400_B101","doi-asserted-by":"publisher","first-page":"G211","DOI":"10.1152\/ajpgi.00040.2019","article-title":"CD8+ T cells regulate liver injury in obesity-related nonalcoholic fatty liver disease","volume":"318","author":"Breuer","year":"2020","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"2023012407301962400_B102","doi-asserted-by":"publisher","first-page":"5129","DOI":"10.1038\/s41598-021-84674-z","article-title":"Hepatic lymphocytes involved in the pathogenesis of pediatric and adult non-alcoholic fatty liver disease","volume":"11","author":"Cairoli","year":"2021","journal-title":"Sci. Rep."},{"key":"2023012407301962400_B103","doi-asserted-by":"publisher","first-page":"563434","DOI":"10.3389\/fimmu.2020.563434","article-title":"A mineralocorticoid receptor deficiency in myeloid cells reduces liver steatosis by impairing activation of CD8+ T cells in a nonalcoholic steatohepatitis mouse model","volume":"11","author":"Mu\u00f1oz-Durango","year":"2020","journal-title":"Front. Immunol."},{"key":"2023012407301962400_B104","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/hep4.1041","article-title":"Hepatic natural killer t-cell and CD8+ T-cell signatures in mice with nonalcoholic steatohepatitis","volume":"1","author":"Bhattacharjee","year":"2017","journal-title":"Hepatol. Commun."},{"key":"2023012407301962400_B105","doi-asserted-by":"publisher","first-page":"eaai7616","DOI":"10.1126\/sciimmunol.aai7616","article-title":"Type I interferon responses drive intrahepatic t cells to promote metabolic syndrome","volume":"2","author":"Ghazarian","year":"2017","journal-title":"Sci. Immunol."},{"key":"2023012407301962400_B106","doi-asserted-by":"publisher","first-page":"4474","DOI":"10.1038\/s41467-021-24734-0","article-title":"CD8+ tissue-resident memory T cells promote liver fibrosis resolution by inducing apoptosis of hepatic stellate cells","volume":"12","author":"Koda","year":"2021","journal-title":"Nat. Commun."},{"key":"2023012407301962400_B107","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.jcmgh.2019.08.004","article-title":"Unique T-cell populations define immune-inflamed hepatocellular carcinoma","volume":"9","author":"Di Blasi","year":"2020","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"2023012407301962400_B108","doi-asserted-by":"publisher","first-page":"1646.e17","DOI":"10.1053\/j.gastro.2016.02.040","article-title":"Tumor-associated neutrophils recruit macrophages and T-regulatory cells to promote progression of hepatocellular carcinoma and resistance to Sorafenib","volume":"150","author":"Zhou","year":"2016","journal-title":"Gastroenterology"},{"key":"2023012407301962400_B109","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1038\/ni.3868","article-title":"Oxidative stress controls regulatory T cell apoptosis and suppressor activity and PD-L1-blockade resistance in tumor","volume":"18","author":"Maj","year":"2017","journal-title":"Nat. Immunol."},{"key":"2023012407301962400_B110","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/nature16969","article-title":"NAFLD causes selective CD4(+) T lymphocyte loss and promotes hepatocarcinogenesis","volume":"531","author":"Ma","year":"2016","journal-title":"Nature"},{"key":"2023012407301962400_B111","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/s41590-018-0044-z","article-title":"The immunology of hepatocellular carcinoma","volume":"19","author":"Ringelhan","year":"2018","journal-title":"Nat. Immunol."},{"key":"2023012407301962400_B112","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1158\/1940-6207.CAPR-20-0200","article-title":"Immune checkpoint inhibition is safe and effective for liver cancer prevention in a mouse model of hepatocellular carcinoma","volume":"13","author":"Chung","year":"2020","journal-title":"Cancer Prev. Res. (Phila)"},{"key":"2023012407301962400_B113","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1053\/j.gastro.2021.06.008","article-title":"Evidence-based management of hepatocellular carcinoma: systematic review and meta-analysis of randomized controlled trials (2002-2020)","volume":"161","author":"Haber","year":"2021","journal-title":"Gastroenterology"},{"key":"2023012407301962400_B114","doi-asserted-by":"publisher","first-page":"6374","DOI":"10.1002\/cam4.4177","article-title":"Metabolic reprogramming of immune cells: Shaping the tumor microenvironment in hepatocellular carcinoma","volume":"10","author":"Xia","year":"2021","journal-title":"Cancer Med."},{"key":"2023012407301962400_B115","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-019-1324-y","article-title":"TOX is a critical regulator of tumour-specific T cell differentiation","volume":"571","author":"Scott","year":"2019","journal-title":"Nature"},{"key":"2023012407301962400_B116","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1002\/hep.30212","article-title":"Characteristics of immune response to tumor-associated antigens and immune cell profile in patients with hepatocellular carcinoma","volume":"69","author":"Inada","year":"2019","journal-title":"Hepatology"},{"key":"2023012407301962400_B117","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.jhep.2022.03.010","article-title":"Metformin treatment rescues CD8+ T-cell response to immune checkpoint inhibitor therapy in mice with NAFLD","volume":"77","author":"Wabitsch","year":"2022","journal-title":"J. Hepatol."},{"key":"2023012407301962400_B118","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/nrendo.2013.256","article-title":"Metformin\u2013mode of action and clinical implications for diabetes and cancer","volume":"10","author":"Pernicova","year":"2014","journal-title":"Nat. Rev. Endocrinol."},{"key":"2023012407301962400_B119","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/s41423-022-00872-3","article-title":"Aberrant cholesterol metabolic signaling impairs antitumor immunosurveillance through natural killer T cell dysfunction in obese liver","volume":"19","author":"Tang","year":"2022","journal-title":"Cell Mol. Immunol."},{"key":"2023012407301962400_B120","doi-asserted-by":"publisher","first-page":"119","DOI":"10.4254\/wjh.v14.i1.119","article-title":"Is there a role of lipid-lowering therapies in the management of fatty liver disease?","volume":"14","author":"Tzanaki","year":"2022","journal-title":"World J. Hepatol."},{"key":"2023012407301962400_B121","doi-asserted-by":"publisher","first-page":"968366","DOI":"10.3389\/fimmu.2022.968366","article-title":"Hepatic damage caused by long-term high cholesterol intake induces a dysfunctional restorative macrophage population in experimental NASH","volume":"13","author":"Maretti-Mira","year":"2022","journal-title":"Front. Immunol."},{"key":"2023012407301962400_B122","doi-asserted-by":"publisher","first-page":"103847","DOI":"10.1016\/j.isci.2022.103847","article-title":"NAFLD indirectly impairs antigen-specific CD8+ T cell immunity against liver cancer in mice","volume":"25","author":"McVey","year":"2022","journal-title":"iScience"},{"key":"2023012407301962400_B123","doi-asserted-by":"publisher","first-page":"5214","DOI":"10.1038\/s41467-018-07402-8","article-title":"An inflammatory-CCRK circuitry drives mTORC1-dependent metabolic and immunosuppressive reprogramming in obesity-associated hepatocellular carcinoma","volume":"9","author":"Sun","year":"2018","journal-title":"Nat. Commun."},{"key":"2023012407301962400_B124","doi-asserted-by":"publisher","first-page":"422","DOI":"10.4049\/jimmunol.1701019","article-title":"Myeloid-derived suppressor cells: immune-suppressive cells that impair antitumor immunity and are sculpted by their environment","volume":"200","author":"Ostrand-Rosenberg","year":"2018","journal-title":"J. Immunol."},{"key":"2023012407301962400_B125","doi-asserted-by":"publisher","first-page":"e0149948","DOI":"10.1371\/journal.pone.0149948","article-title":"Characterization of liver monocytic myeloid-derived suppressor cells and their role in a murine model of non-alcoholic fatty liver disease","volume":"11","author":"Yao","year":"2016","journal-title":"PloS ONE"},{"key":"2023012407301962400_B126","doi-asserted-by":"publisher","first-page":"357","DOI":"10.3389\/fonc.2018.00357","article-title":"Transforming Growth Factor-\u03b2-induced cell plasticity in liver fibrosis and hepatocarcinogenesis","volume":"8","author":"Fabregat","year":"2018","journal-title":"Front. Oncol."},{"key":"2023012407301962400_B127","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1093\/intimm\/dxv038","article-title":"The expanding family of regulatory B cells","volume":"27","author":"Mauri","year":"2015","journal-title":"Int. Immunol."},{"key":"2023012407301962400_B128","doi-asserted-by":"publisher","first-page":"299.e5","DOI":"10.1016\/j.immuni.2018.01.006","article-title":"Interleukin-10 directly inhibits CD8+ T cell function by enhancing N-glycan branching to decrease antigen sensitivity","volume":"48","author":"Smith","year":"2018","journal-title":"Immunity"},{"key":"2023012407301962400_B129","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/hep.25497","article-title":"Hypoxia and hypoxia inducible factors: diverse roles in liver diseases","volume":"55","author":"Nath","year":"2012","journal-title":"Hepatology"},{"key":"2023012407301962400_B130","doi-asserted-by":"publisher","first-page":"3419","DOI":"10.1007\/s00018-016-2222-1","article-title":"Hypoxia-regulated mechanisms in the pathogenesis of obesity and non-alcoholic fatty liver disease","volume":"73","author":"Lefere","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"key":"2023012407301962400_B131","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.mam.2018.09.002","article-title":"Liver fibrosis. Pathophysiology, pathogenetic targets and clinical issues","volume":"65","author":"Parola","year":"2019","journal-title":"Mol. Aspect Med"},{"key":"2023012407301962400_B132","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.3390\/cells10071764","article-title":"Hypoxia, hypoxia-inducible factors and liver fibrosis","volume":"10","author":"Foglia","year":"2021","journal-title":"Cells"},{"key":"2023012407301962400_B133","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1016\/j.jhep.2014.08.025","article-title":"Hypoxia inducible factors in liver disease and hepatocellular carcinoma: current understanding and future directions","volume":"61","author":"Wilson","year":"2014","journal-title":"J. Hepatol."},{"key":"2023012407301962400_B134","first-page":"3","article-title":"Hypoxia-inducible factors in hepatocellular carcinoma (Review)","volume":"43","author":"Guo","year":"2020","journal-title":"Oncol. Rep."},{"key":"2023012407301962400_B135","doi-asserted-by":"publisher","first-page":"5052","DOI":"10.1172\/JCI137553","article-title":"Hypoxia-inducible factors and innate immunity in liver cancer","volume":"130","author":"Yuen","year":"2020","journal-title":"J. Clin. Invest."},{"key":"2023012407301962400_B136","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1056\/NEJMra1011165","article-title":"Oxygen sensing, homeostasis, and disease","volume":"365","author":"Semenza","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"2023012407301962400_B137","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.cell.2012.01.021","article-title":"Hypoxia-inducible factors in physiology and medicine","volume":"148","author":"Semenza","year":"2012","journal-title":"Cell"},{"key":"2023012407301962400_B138","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.molcel.2008.04.009","article-title":"Oxygen sensing by metazoans: the central role of HIF hydroxylase pathway","volume":"30","author":"Kaelin","year":"2008","journal-title":"Mol. Cell"},{"key":"2023012407301962400_B139","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1038\/s41581-019-0182-z","article-title":"Mechanisms of hypoxia signaling: new implications for nephrology","volume":"115","author":"Sch\u00f6del","year":"2019","journal-title":"Nat. Rev. Nephrol."},{"key":"2023012407301962400_B140","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.3390\/cells10071715","article-title":"Hypoxia, metabolic reprogramming, and drug resistance in liver Cancer","volume":"10","author":"Bao","year":"2021","journal-title":"Cells"},{"key":"2023012407301962400_B141","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32629","article-title":"Noncellular components in the liver cancer stem cell niche: biology and potential clinical implications","author":"Lam","year":"2022","journal-title":"Hepatology"},{"key":"2023012407301962400_B142","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/ncb3330","article-title":"The ever-expanding role of HIF in tumour and stromal biology","volume":"18","author":"LaGory","year":"2016","journal-title":"Nat. Cell Biol."},{"key":"2023012407301962400_B143","doi-asserted-by":"publisher","first-page":"286","DOI":"10.3389\/fonc.2017.00286","article-title":"Non-canonical mechanisms regulating hypoxia-inducible factor 1 alpha in cancer","volume":"7","author":"Iommarini","year":"2017","journal-title":"Front. Oncol."},{"key":"2023012407301962400_B144","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.jhep.2021.12.028","article-title":"Severe hypoxia is a typical characteristic of human hepatocellular carcinoma: Scientific fact or fallacy?","volume":"76","author":"Cramer","year":"2022","journal-title":"J. Hepatol."},{"key":"2023012407301962400_B145","doi-asserted-by":"publisher","first-page":"525","DOI":"10.3748\/wjg.v10.i4.525","article-title":"Expression of HIF-2alpha\/EPAS1 in hepatocellular carcinoma","volume":"10","author":"Bangoura","year":"2004","journal-title":"World J. Gastroenterol."},{"key":"2023012407301962400_B146","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.3748\/wjg.v11.i11.1705","article-title":"Expression of hypoxia-inducible factor 1alpha and vascular endothelial growth factor in hepatocellular carcinoma: Impact on neovascularization and survival","volume":"11","author":"Huang","year":"2005","journal-title":"World J. Gastroenterol."},{"key":"2023012407301962400_B147","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1002\/hep.23597","article-title":"Roles of hypoxia-inducible factor-1alpha (HIF-1alpha) versus HIF-2alpha in the survival of hepatocellular tumor spheroids","volume":"51","author":"Menrad","year":"2010","journal-title":"Hepatology"},{"key":"2023012407301962400_B148","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1111\/j.1349-7006.2011.02177.x","article-title":"Downregulating hypoxia-inducible factor-2\u03b1 improves the efficacy of doxorubicin in the treatment of hepatocellular carcinoma","volume":"103","author":"He","year":"2012","journal-title":"Cancer Sci."},{"key":"2023012407301962400_B149","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1002\/hep.26188","article-title":"Hypoxia inducible factor 2 alpha inhibits hepatocellular carcinoma growth through the transcription factor dimerization partner 3\/E2F transcription factor 1-dependent apoptotic pathway","volume":"57","author":"Sun","year":"2013","journal-title":"Hepatology"},{"key":"2023012407301962400_B150","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1016\/j.cellsig.2014.01.026","article-title":"Upregulation of HIF-2\u03b1 induced by sorafenib contributes to the resistance by activating the TGF-\u03b1\/EGFR pathway in hepatocellular carcinoma cells","volume":"26","author":"Zhao","year":"2014","journal-title":"Cell. Signal."},{"key":"2023012407301962400_B151","doi-asserted-by":"publisher","first-page":"2708","DOI":"10.1038\/bjc.2014.246","article-title":"SERPINB3 is associated with TGF-\u03b21 and cytoplasmic \u03b2-catenin expression in hepatocellular carcinomas with poor prognosis","volume":"110","author":"Turato","year":"2014","journal-title":"Br. J. Cancer"},{"key":"2023012407301962400_B152","doi-asserted-by":"publisher","first-page":"34571","DOI":"10.18632\/oncotarget.8952","article-title":"Downregulation and pro-apoptotic effect of hypoxia-inducible factor 2 alpha in hepatocellular carcinoma","volume":"7","author":"Yang","year":"2016","journal-title":"Oncotarget"},{"key":"2023012407301962400_B153","doi-asserted-by":"publisher","first-page":"10839","DOI":"10.18632\/aging.102488","article-title":"HIF-2\u03b1 upregulation mediated by hypoxia promotes NAFLD-HCC progression by activating lipid synthesis via the PI3K-AKT-mTOR pathway","volume":"11","author":"Chen","year":"2019","journal-title":"Aging (Albany NY)"},{"key":"2023012407301962400_B154","doi-asserted-by":"publisher","first-page":"4527","DOI":"10.1128\/MCB.00200-09","article-title":"Hypoxia-inducible factor 2 regulates hepatic lipid metabolism","volume":"29","author":"Rankin","year":"2009","journal-title":"Mol. Cell. Biol."},{"key":"2023012407301962400_B155","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.1002\/hep.29754","article-title":"Hypoxia-inducible factor 2\u03b1 drives nonalcoholic fatty liver progression by triggering hepatocyte release of histidine-rich glycoprotein","volume":"67","author":"Morello","year":"2018","journal-title":"Hepatology"},{"key":"2023012407301962400_B156","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.1172\/JCI39506","article-title":"Hypoxia-inducible factor 2alpha regulates macrophage function in mouse models of acute and tumor inflammation","volume":"120","author":"Imtiyaz","year":"2010","journal-title":"J. Clin. Invest."},{"key":"2023012407301962400_B157","doi-asserted-by":"publisher","first-page":"910526","DOI":"10.3389\/fimmu.2022.910526","article-title":"SerpinB3 as a pro-inflammatory mediator in the progression of experimental non-alcoholic fatty liver disease","volume":"13","author":"Novo","year":"2022","journal-title":"Front Immunol."},{"key":"2023012407301962400_B158","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1002\/hep.30593","article-title":"Blocking triggering receptor expressed on myeloid cells-1-positive tumor-associated macrophages induced by hypoxia reverses immunosuppression and anti-programmed cell death ligand 1 resistance in liver cancer","volume":"70","author":"Wu","year":"2019","journal-title":"Hepatology"},{"key":"2023012407301962400_B159","doi-asserted-by":"publisher","first-page":"7081","DOI":"10.1128\/MCB.00773-08","article-title":"Hypoxia-associated factor, a novel E3-ubiquitin ligase, binds and ubiquitinates hypoxia-inducible factor 1alpha, leading to its oxygen-independent degradation","volume":"28","author":"Koh","year":"2008","journal-title":"Mol. Cell. Biol."},{"key":"2023012407301962400_B160","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1002\/hep.28468","article-title":"A new HIF-1\u03b1\/RANTES-driven pathway to hepatocellular carcinoma mediated by germline haploinsufficiency of SART1\/HAF in mice","volume":"63","author":"Koh","year":"2016","journal-title":"Hepatology"},{"key":"2023012407301962400_B161","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1084\/jem.20040624","article-title":"Hypoxia-induced neutrophil survival is mediated by HIF-1alpha-dependent NF-kappaB activity","volume":"201","author":"Walmsley","year":"2005","journal-title":"J. Exp. Med."},{"key":"2023012407301962400_B162","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.semcancer.2013.02.005","article-title":"Modulation of neutrophil granulocytes in the tumor microenvironment: mechanisms and consequences for tumor progression","volume":"23","author":"Dumitru","year":"2013","journal-title":"Semin. Cancer Biol."},{"key":"2023012407301962400_B163","doi-asserted-by":"publisher","first-page":"6818","DOI":"10.1038\/ncomms7818","article-title":"NF\u03baB1 is a suppressor of neutrophil-driven hepatocellular carcinoma","volume":"6","author":"Wilson","year":"2015","journal-title":"Nat. Commun."},{"key":"2023012407301962400_B164","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1002\/hep.28655","article-title":"Hypoxia induces myeloid-derived suppressor cell recruitment to hepatocellular carcinoma through chemokine (C-C motif) ligand 26","volume":"64","author":"Chiu","year":"2016","journal-title":"Hepatology"},{"key":"2023012407301962400_B165","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1084\/jem.20100587","article-title":"HIF-1\u03b1 regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment","volume":"207","author":"Corzo","year":"2010","journal-title":"J. Exp. Med."},{"key":"2023012407301962400_B166","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1084\/jem.20131916","article-title":"PD-L1 is a novel direct target of HIF-1\u03b1, and its blockade under hypoxia enhanced MDSC-mediated T cell activation","volume":"211","author":"Noman","year":"2014","journal-title":"J. Exp. Med."}],"container-title":["Bioscience Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/bioscirep\/article-pdf\/doi\/10.1042\/BSR20221271\/942246\/bsr-2022-1271c.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/bioscirep\/article-pdf\/doi\/10.1042\/BSR20221271\/942246\/bsr-2022-1271c.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,24]],"date-time":"2023-01-24T07:30:38Z","timestamp":1674545438000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/bioscirep\/article\/43\/1\/BSR20221271\/232415\/Inflammatory-processes-involved-in-NASH-related"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":166,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1,31]]}},"URL":"https:\/\/doi.org\/10.1042\/bsr20221271","relation":{},"ISSN":["0144-8463","1573-4935"],"issn-type":[{"value":"0144-8463","type":"print"},{"value":"1573-4935","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,1]]},"published":{"date-parts":[[2023,1]]},"article-number":"BSR20221271"}}